Mergin 0.125mg Injection

Explore detailed information about Mergin 0.125mg Injection, a medication containing Methylergometrine (0.125mg) from the trusted Shrinivas Gujarat Laboratories Pvt Ltd brand. Discover its primary uses for Induction of labour,Post-delivery bleeding and delve deeper into its specific details to understand how Mergin 0.125mg Injection can play a role in your health and well-being. Add it to your wishlist or compare it with other products.

MRP: ₹ 20.5
Packing: 1.0 ml in 1 vial
Salt Combination: Methylergometrine (0.125mg)
Brand: Shrinivas Gujarat Laboratories Pvt Ltd
Uses: Induction of labour,Post-delivery bleeding

Description

Mergin 0.125mg Injection is a medicine used to control bleeding from the uterus, that may occur after childbirth or an abortion
It works on the smooth muscle of the uterus and increases tone, rate, and amplitude of contractions thus reduces blood loss
Mergin 0.125mg Injection is not for a self-administered, it is given as an injection into the veins or muscles by the doctor at hospital setting
It should be taken as your doctor's advice
The dose and how often you take it depends on what you are taking it for
Your doctor will decide how much you need to improve your symptoms.
The most common side effects of this medicine include headache, increase in blood pressure and seizure
If these bother you or appear serious, let your doctor know
There may be ways of reducing or preventing them
Generally, alcohol should be avoided while taking this medicine.
Before taking this medicine, let your doctor know if you have ever had heart disease or you have high blood pressure
Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works.

Cautions

Liver:	CONSULT YOUR DOCTOR: There is limited information available on the use of Mergin 0.125mg Injection in patients with liver disease. Please consult your doctor.
Kidney:	CONSULT YOUR DOCTOR: There is limited information available on the use of Mergin 0.125mg Injection in patients with kidney disease. Please consult your doctor.
Driving:	CONSULT YOUR DOCTOR: It is not known whether Mergin 0.125mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Breast feeding:	CAUTION: Mergin 0.125mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Pregnency:	UNSAFE: Mergin 0.125mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Mergin 0.125mg Injection. Please consult your doctor.
Drug Action:	Uterotonics & Abortificients
Therapeutic class:	GYNAECOLOGICAL
Habit Forming:	No
Chemical Class:	Ergolines